Landscape Capital Management’s NovoCure NVCR Stock Holding History

Landscape Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,332	Closed	-$161K	–	844
2024 Q1	$161K	Buy	+10,332	New	+$152K	0.01%	639
2022 Q4	–	Sell	-26,891	Closed	-$2.04M	–	914
2022 Q3	$2.04M	Buy	+26,891	New	+$2.1M	0.27%	76
2021 Q4	–	Sell	-23,885	Closed	-$2.77M	–	868
2021 Q3	$2.77M	Buy	23,885 +9,246	+63%	+$1.4M	0.39%	63
2021 Q2	$3.25M	Sell	14,639 -9,801	-40%	-$1.91M	0.4%	67
2021 Q1	$3.23M	Buy	24,440 +17,306	+243%	+$2.74M	0.51%	47
2020 Q4	$1.23M	Buy	7,134 +778	+12%	+$106K	0.2%	108
2020 Q3	$707K	Buy	+6,356	New	+$508K	0.13%	139

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Landscape Capital Management's NVCR Position: Q2 2024 in Review

Landscape Capital Management sold out of NovoCure (NVCR) in Q2 2024, closing a stake of 10,332 shares — an estimated $161K sold.

Landscape Capital Management first reported a position in NVCR in Q3 2020 and held it in 7 quarters. The position peaked at $3.25M in Q2 2021. 236 funds tracked by Wall St. Rank hold NVCR as of Q2 2024.

Landscape Capital Management reported no remaining NovoCure position as of Q2 2024 after selling out during the quarter.
Landscape Capital Management sold 10,332 NovoCure shares in Q2 2024, an estimated $161K.
Landscape Capital Management first reported a position in NovoCure in Q3 2020 and held it in 7 quarters.
Landscape Capital Management's NovoCure position peaked at $3.25M in Q2 2021.
236 funds tracked by Wall St. Rank held NovoCure as of Q2 2024.

Based on Landscape Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.